Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization

British Journal of Dermatology

Volumn 142, Issue 3, 2000, Pages 401-412

  Kimber, Ian ^b   Cumberbatch, M ^b   Dearman, R J ^b   Bhushan, M ^a   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Chemokines; Cytokines; Dendritic cells; Langerhans cells; Migration

Indexed keywords

CHEMOKINE; CYTOKINE;

CELL MIGRATION; DENDRITIC CELL; EPIDERMIS; EPIDERMIS CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; KERATINOCYTE; LANGERHANS CELL; LYMPH NODE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE;

ANIMALS; CELL MOVEMENT; CHEMOKINES; CYTOKINES; IMMUNITY, CELLULAR; LANGERHANS CELLS; LYMPH NODES; MICE;

EID: 3042747086     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03349.x     Document Type: Review

References (159)

1. 1 Hart DJN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245-87.
2. 2 Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9: 10-16.
3. 3 Watts C. Inside the gearbox of the dendritic cell. Nature 1997; 388: 724-5.
4. 4 Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
5. + cells are capable of initiating delayed-type hypersensitivity responses. J Invest Dermatol 1990; 94: 267-72.
6. 6 Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 1993; 93: 2587-96.
7. 7 Nestle FO, Zheng X-G, Thompson CB et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypically and functionally distinct subsets. J Immunol 1993; 151: 6535-45.
8. 8 Bacci S, Alard P, Dai R et al. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity. Eur J Immunol 1997; 27: 442-8.
9. 9 Sato K, Imai Y, Irimura T. Contribution of dermal macrophage trafficking in the sensitization phase of contact hypersensitivity. J Immunol 1998; 61: 6835-44.
10. 10 Strunk D, Egger C, Leitner G et al. A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood. J Exp Med 1997; 185: 1131-6.
11. 11 Romani N, Schuler G. The immunologic properties of epidermal Langerhans cells as part of the dendritic cell system. Springer Semin Immunopathol 1992; 13: 265-79.
12. 12 Larregina A, Morelli A, Kolkowski E, Fainboim L. Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short term culture. Immunology 1996; 87: 317-25.
13. 13 Lappin MB, Kimber I, Norval M. The role of dendritic cells in cutaneous immunity. Arch Dermatol Res 1996; 288: 109-21.
14. 14 Schreiber S, Kilgus O, Payer E et al. Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 1992; 149: 3525-34.
15. 15 Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992; 89: 1398-402.
16. 16 Heufler C, Topar G, Koch F et al. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 1992; 176: 1221-6.
17. 17 Matsue H, Cruz PD Jr, Bergstresser PR, Takashima A. Langerhans cells are the major source of mRNA for IL-1β and MIP-1α among unstimulated mouse epidermal cells. J Invest Dermatol 1992; 99: 537-41.
18. 18 Cumberbatch M, Dearman RJ, Kimber I. Constitutive and inducible expression of interleukin-6 by epidermal Langerhans cells and lymph node dendritic cells. Immunology 1996; 87: 513-18.
19. 19 Kang K, Kubin M, Cooper KD et al. IL-12 synthesis by human Langerhans cells. J Immunol 1996; 156: 1402-7.
20. 20 Blauvelt A, Asada H, Klaus-Kovtun V et al. Interleukin-15 mRNA is expressed by human keratinocytes, Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol 1996; 106: 1047-52.
21. 21 Mohamadzadeh M, Poltorak AN, Bergstresser PR et al. Dendritic cells produce macrophage inflammatory protein-1γ, a new member of the C-C chemokine family. J Immunol 1996; 156: 3102-6.
22. 22 Stoll S, Jonuleit H, Schmitt E et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998; 28: 3231-9.
23. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF and TNF-α. J Exp Med 1996; 184: 695-706.
24. + hematopoietic progenitor cells. Blood 1996; 87: 1292-302.
25. 25 Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs. Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen and lymph nodes. J Immunol 1997; 159: 565-73.
26. + dendritic cells. Immunity 1998; 9: 839-47.
27. + dendritic cells (DC) veto cells? The role of CD8 on DC in development and in the regulation of CD4 and CD8 T cell responses. Int Immunol 1996; 9: 1061-4.
28. 28 Kronin V, Winkel K, Suss G et al. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol 1996; 157: 3819-27.
29. 29 Kapsenberg ML, Hilkens CMU, Wierenga EA, Kalinski P. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr Opin Immunol 1998; 10: 607-13.
30. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999; 189: 587-92.
31. 31 Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999; 96: 1036-41.
32. 32 Rissoan M-C, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183-6.
33. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med 1999; 189: 593-8.
34. 34 Knight SC, Iqball S, Roberts MS et al. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur J Immunol 1998; 28: 1636-44.
35. 35 Streilein JW, Grammer SF. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol 1989; 143: 3925-33.
36. 36 Streilein JW, Grammer SF, Yoshikawa T et al. Functional dichotomy between Langerhans cells that present antigen to naive and memory/effector T lymphocytes. Immunol Rev 1990; 117: 159-83.
37. 37 Girolomoni G, Cruz PD Jr, Bergstresser PR. Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans cells: a paradigm for antigen processing. J Invest Dermatol 1990; 94: 753-60.
38. 38 Bartosik J. Cytomembrane-derived Birbeck granules transport horseradish peroxidase to the endosomal compartment in the human Langerhans cell. J Invest Dermatol 1992; 99: 53-8.
39. 39 Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigen by Langerhans cells in vitro. J Exp Med 1993; 178: 509-19.
40. 40 Kleijmeer MJ. Oorschot VMJ, Geuze HJ. Human resident Langerhans cells display a lysosomal compartment enriched in MHC class II. J Invest Dermatol 1994; 103: 516-23.
41. 41 Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161: 526-46.
42. 42 Silberberg-Sinakin I, Gigli I, Baer RL, Thorbecke GJ. Langerhans cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages. Immunol Rev 1980; 53: 203-32.
43. 43 Knight SC, Krejci J, Malkovsky M et al. The role of dendritic cells in the initiation of immune responses to contact sensitizers. 1 In vivo exposure to antigen. Cell Immunol 1985; 94: 427-34.
44. 44 Macatonia SE, Edwards AJ, Knight SC. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 1986; 59: 509-14.
45. 45 Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 1987; 166: 1654-67.
46. 46 Kinnaird A, Peters SW, Foster JR, Kimber I. Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int Arch Allergy Appl Immunol 1989; 89: 202-10.
47. 47 Kimber I, Kinniaird A, Peters SW, Mitchell JA. Correlation between lymphocyte proliferative responses and dendritic cell migration to regional lymph nodes following skin painting with contact-sensitizing agents. Int Arch Allergy Appl Immunol 1990; 93: 47-53.
48. 48 Kripke ML, Munn CG, Jeevan A et al. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-8.
49. 49 Kimber I, Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol Appl Pharmacol 1992; 117: 137-46.
50. 50 Kimber I, Dearman RJ, Cumberbatch M, Huby RJD. Langerhans cells and chemical allergy. Curr Opinion Immunol 1998; 10: 614-19.
51. 51 Moodycliffe AM, Kimber I, Norval M. The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology 1992; 77: 394-9.
52. 52 Cumberbatch M, Scott RC, Basketter DA et al. Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation. Toxicology 1993; 77: 181-91.
53. 53 Witmer-Pack MD, Olivier W, Valinsky J et al. Granulocyte/ macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 1987; 166: 1484-98.
54. 54 Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988; 167: 700-5.
55. 55 Picut CA, Lee CS, Dougherty EP, Anderson KL, Lewis RM. Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. J Invest Dermatol 1988; 90: 201-6.
56. 56 Koch F, Heufler C, Kampgen E et al. Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulating factor, does not induce their functional maturation. J Exp Med 1990; 171: 159-72.
57. 57 Furue M, Chang CH, Tamaki K. Interleukin-1 but not tumour necrosis factor alpha synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells. Br J Dermatol 1996; 135: 194-8.
58. 58 Ozawa H, Nakagawa S, Tagami H, Aiba S. Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 1996; 106: 441-5.
59. 59 Cumberbatch M, Kimber I. Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology 1990; 71: 404-10.
60. 60 Cumberbatch M, Gould SJ, Peters SW, Kimber I. MHC class II expression by Langerhans cells and lymph node dendritic cells: possible evidence for the maturation of Langerhans cells following contact sensitization. Immunology 1991; 74: 414-19.
61. 61 Larsen CP, Ritchie SC, Pearson TC et al. Functional expression of the costimulatory molecule, B7/BB1, in murine dendritic cell populations. J Exp Med 1992; 176: 1215-20.
62. 62 Hart DNJ, Starling GC, Calder VL, Fernando NS. B7/BB1 is a leukocyte differentiation antigen on human dendritic cells induced by activation. Immunology 1993; 79: 616-20.
63. 63 Razi-Wolf Z, Falo LD Jr, Reiser H. Expression and function of the costimulatory molecule B7 on murine Langerhans cells: evidence for an alternative CTLA-4 ligand. Eur J Immunol 1994; 24: 805-11.
64. 64 Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994; 180: 1849-60.
65. 65 Romani N, Koide S, Crowley M et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented by immature, epidermal Langerhans cells. J Exp Med 1989; 169: 1169-78.
66. 66 Romani N, Lenz A, Glassel H et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989; 93: 600-9.
67. 67 Stossel H, Koch F, Kampgen E et al. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med 1990; 172: 1471-82.
68. 68 Pure E, Inaba K, Crowley MT et al. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatability complex class II molecules and expression of invariant chain. J Exp Med 1990; 172: 1459-69.
69. 69 Pierre P, Turley SJ, Gatti E et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997; 388: 787-92.
70. 70 Kimber I, Holliday MR, Dearman RJ. Cytokine regulation of chemical sensitization. Toxicol Lett 1995; 82/83: 491-6.
71. 71 Holliday MR, Dearman RJ, Basketter DA, Kimber I. Stimulation by oxazolone of increased IL-6, but not IL-10, in the skin of mice. Toxicology 1996; 106: 237-42.
72. 72 Holliday MR, Dearman RJ, Corsini E et al. Selective stimulation of cutaneous interleukin 6 expression by skin allergens. J Appl Toxicol 1996; 16: 65-70.
73. 73 Holliday MR, Corsini E, Smith S et al. Differential induction of TNF-α and IL-6 by topically applied chemicals. Am J Contact Dermatol 1997; 8: 158-64.
74. 74 Flint MS, Dearman RJ, Kimber I, Hotchkiss SAM. Production and in situ localization of cutaneous tumour necrosis factor α (TNF-α) and interleukin 6 (IL-6) following skin sensitization. Cytokine 1998; 10: 213-19.
75. 75 Cumberbatch M, Kimber I. Dermal TNF-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology 1992; 75: 257-63.
76. 76 Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumour necrosis factor α (TNF-α). J Invest Dermatol 1992; 99: 48-50S.
77. 77 Cumberbatch M, Fielding I, Kimber I. Modulation of epidermal Langerhans cell frequency by TNF-α. Immunology 1994; 81: 395-401.
78. 78 Groves RW, Alien MH, Ross EL et al. Tumour necrosis factor α is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995; 132: 345-52.
79. 79 Cumberbatch M, Griffiths CEM, Tucker SC et al. Tumour necrosis factor-α induces Langerhans cell migration in humans. Br J Dermatol 1999; 141: 192-200.
80. 80 Cumberbatch M, Kimber I. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunol 1995; 84: 31-5.
81. 81 Kimber I, Cumberbatch M, Dearman RJ et al. Regulation by lactoferrin of epidermal Langerhans cell migration. In: Advances in Lactoferrin Research (Spik G, Legrand D, Mazurier J, Pierce A, Perraudin J-P, eds). New York: Plenum Press, 1998: 251-5.
82. 82 Cumberbatch M, Dearman RJ, Kimber I. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals. Immunopharmacology 1999; 41: 235-43.
83. 83 Iofireda MD, Whitaker D, Murphy GF. Mast cell degranulation upregulates α6 integrins on epidermal Langerhans cells. J Invest Dermatol 1993; 101: 150-4.
84. 84 Wille JJ, Kydonieus AF, Murphy GF. cis-Urocanic acid induces mast cell degranulation and release of preformed TNF-α; a possible mechanism linking UVB and cis-urocanic acid to immunosuppression of contact hypersensitivity. Skin Pharmacol Appl Skin Physiol 1999; 12: 18-27.
85. 85 Lewis M, Tartaglia LA, Lee A et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 1991; 88: 2830-4.
86. 86 Wang B, Kondo S, Shivji GM et al. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans cells. Immunology 1996; 88: 284-8.
87. 87 Wang B, Fujisawa H, Zhuang L et al. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997; 159: 6148-55.
88. 88 Ryffel B, Brockhaus M, Greiner B, Mihatsch MJ, Gudat F. Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology 1991; 74: 446-52.
89. 89 Moodycliffe AM, Kimber I, Norval M. Role of tumour necrosis factor-α in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunol 1994; 81: 79-84.
90. 90 Stoitzner P, Koch F, Janke K, Romani N. Differential effects of TNF-α in the migration of murine Langerhans cells. J Invest Dermatol 1997; 109: 265 (Abstr.).
91. 91 Cumberbatch M, Dearman RJ, Kimber I. Induction by tumour necrosis factor α of dose-related changes in Langerhans cell frequency in mice. Arch Dermatol Res 1999; 291: 453-8.
92. 92 Vermeer M, Streilein JW. Ultraviolet B light-induced alterations in epidermal Langerhans cells mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed 1990; 7: 258-65.
93. 93 Cumberbatch M, Dearman RJ, Kimber I. Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α. Arch Dermatol Res 1997; 289: 277-84.
94. 94 Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in the skin. J Immunol 1993; 150: 3698-704.
95. 95 Cumberbatch M, Dearman RJ. Kimber I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology 1997; 92: 388-95.
96. 96 Cumberbatch M, Dearman RJ, Kimber I. Characteristics and regulation of the expression of interleukin 1 receptors by murine Langerhans cells and keratinocytes. Arch Dermatol Res 1998-29; 290: 688-95.
97. 97 Cumberbatch M, Dearman RJ, Kimber I. Langerhans cell migration in mice requires intact type 1 interleukin 1 receptor (IL-1RI) function. Arch Dermatol Res 1999; 291: 357-61.
98. 98 Shornick LP, De Togni P, Mariathasan S et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med 1996; 183: 1427-36.
99. 99 Tang A, Amagai M, Granger LG et al. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82-5.
100. 100 Blauvelt A, Katz SI, Udey MC. Human Langerhans cells express E-cadherin. J Invest Dermatol 1995; 104: 293-6.
101. 101 Borkowski TA, van Dyke BJ, Schwarzenberger K et al. Expression of E-cadherin by murine dendritic cells. E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur J Immunol 1994; 24: 2767-74.
102. 102 Cumberbatch M, Dearman RJ, Kimber I. Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison. Arch Dermatol Res 1996; 288: 739-44.
103. 103 Schwarzenberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 1996; 106: 553-8.
104. 104 Jakob T, Udey MC. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 1998; 160: 4067-73.
105. 105 Cumberbatch M, Peters SW, Gould SJ, Kimber I. Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cells. Immunol Lett 1992; 32: 105-10.
106. 106 Ma J, Wing J-H, Guo Y-J et al. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol 1994; 158: 389-99.
107. 107 Murayama M, Yasuda H, Nishimura Y, Asahi M. Suppression of mouse contact hypersensitivity after treatment with antibodies to leukocyte function-associated antigen-1 and intercellular adhesion molecule-1. Arch Dermatol Res 1997; 289: 98-103.
108. 108 Gabrilovich DI, Woods GM, Patterson S et al. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules. Immunology 1994; 82: 82-7.
109. 109 Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and is downregulated by tumor necrosis factor α. J Exp Med 1994; 179: 1109-18.
110. 110 Osada A, Nakashima H, Furue M, Tamaki K. Up-regulation of CD44 expression by tumor necrosis factor-α is neutralized by interleukin-10 in Langerhans cells. J Invest Dermatol 1995; 105: 124-7.
111. 111 Weiss JM, Sleeman J, Renki AC et al. An essential role for CD44 isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol 1997; 137: 1137-47.
112. 112 Weiss JM, Renki AC, Sleeman J et al. CD44 variant isoforms are essential for the function of epidermal Langerhans cells and dendritic cells. Cell Adhesion Comm 1998; 6: 157-60.
113. 113 Williams NJ, Harvey JJ, Duncan I et al. IL-12 restores dendritic cell function and cell mediated immunity in retrovirus infected mice. Cell Immunol 1998; 183: 121-30.
114. 114 Price AA, Cumberbatch M, Kimber I, Ager A. α6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med 1997; 186: 1725-35.
115. 115 Kobayashi Y. Langerhans cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology 1997; 90: 496-501.
116. 116 Uchi H, Imayama S, Kobayashi Y, Furue M. Langerhans cells express matrix metalloproteinase-9 in the human epidermis. J Invest Dermatol 1998; 111: 1232-3.
117. 117 Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157: 4149-65.
118. 118 Wang M, Qin X, Mudgett JS et al. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci USA 1999; 96: 6885-9.
119. 119 Shibaki A, Meunier L, Ra C et al. Differential responsiveness of Langerhans cell subsets of varying phenotypic states in normal human epidermis. J Invest Dermatol 1995; 104: 42-6.
120. 120 Ariizumi K, Kitajima T, Bergstresser PR, Takashima A. Interleukin-1β converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines. Eur J Immunol 1995; 25: 2137-41.
121. 121 Randolph GJ, Beaulieu S, Pope M et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from the skin via afferent lymphatic vessels. Proc Natl Acad Sci USA 1998; 95: 6924-9.
122. 122 Girolomoni G, Santantonio ML, Pastore S et al. Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP: in vitro evidence supporting a protective role of membrane ATPase. J Invest Dermatol 1993; 100: 282-7.
123. 123 Perregauz D, Gabel CA. Interleukin-1β maturation and release in response to ATP and nigericin. J Biol Chem 1994; 269: 15195-203.
124. 124 Griffiths RJ, Stam EJ, Downs JT, Otterness IG. ATP induces the release of IL-1 from LPS-primed cells in vivo. J Immunol 1995; 154: 2821-8.
125. 125 Ferrari D, Chiozzi P, Falzoni S et al. Extracellular ATP triggers IL-1β release by activating the purinergir P2Z receptor of human macrophages. J Immunol 1997; 159: 1451-8.
126. 126 Di Virgilio F. The P2Z purinoreceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 1995; 16: 524-8.
127. 127 Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149: 92-5.
128. 128 Berg DJ, Leach MW, Kuhn R et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995; 182: 99-108.
129. 129 Peguet-Navarro J, Moulon C, Cauz C et al. Interleukin 10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol 1994; 24: 884-91.
130. 130 Chang C-H, Furue M, Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur J Immunol 1995; 25: 395-8.
131. 131 Ozawa H, Aiba S, Nakagawa S, Tagami H. Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol 1996; 26: 648-52.
132. 132 Steinbrink K, Wolfl M, Jonuleit H et al. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772-80.
133. mapk are involved in IL-10 mediated selective repression of TNF-α-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J Immunol 1999; 162: 3865-72.
134. 134 Wang B, Zhuang L, Fujisawa Fh et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999; 162: 277-83.
135. 135 Hedrick JA, Zlotnik A. Chemokines and lymphocyte biology. Curr Opin Immunol 1996; 8: 343-7.
136. 136 Rollins BJ. Chemokines. Blood 1997; 90: 909-28.
137. 137 Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705.
138. 138 Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
139. 139 Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19: 568-74.
140. 140 Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 1999; 20: 254-7.
141. 141 Yoshie O, Imai T, Nomiyama H. Novel lymphocyte specific CC chemokines and their receptors. J Leuk Biol 1997; 62: 634-44.
142. 142 Dieu MC, Vanbervliet B, Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998; 188: 373-86.
143. 143 Delgado E, Finkel V, Baggiolini M et al. Mature dendritic cells respond to SDF-1, but not to several beta-chemokines. Immunobiology 1998; 198: 490-500.
144. 144 Lin C-L, Sun RM, Rahdon RA et al. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur J Immunol 1998; 28: 4114-22.
145. 145 Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998; 28: 2760-9.
146. 146 Sozzani S, Allavena P, D'Amico G et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 1998; 161: 1083-6.
147. 147 Yanagihara S, Komura E, Nagafune J et al. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 1998; 161: 3096-102.
148. 148 Lane PJL, Brocker T. Developmental regulation of dendritic cell function. Curr Opin Immunol 1999; 11: 308-13.
149. 149 Gunn MD, Tangemann K, Tam C et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998; 95: 258-63.
150. 150 Hedrick JA, Zlotnik A. Identification and characterization of a novel beta chemokine containing six conserved cysteines. J Immunol 1997; 159: 1589-93.
151. 151 Yoshida R, Imai T, Hieshima K et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 1997; 272: 13803-9.
152. 152 Rossi DL, Vicari AP, Franz-Bacon K et al. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3α and MIP-3β. J Immunol 1997; 158: 1033-6.
153. 153 Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 1998; 188: 181-91.
154. 154 Cyster JG. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999; 189: 447-50.
155. 155 Kellermann S-A, Hudak S, Oldham ER et al. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro-and in vivo-derived dendritic cells. J Immunol 1999; 162: 3859-64.
156. 156 Sullusto F, Palermo B, Lenig D et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999; 29: 1617-25.
157. 157 Gunn MD, Kyuwa S, Tam C et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189: 451-60.
158. 158 Saeki H, Moore AM, Brown MJ, Hwang ST. Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 1999; 162: 2472-5.
159. 159 Tang HL, Cyster JG. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999; 284: 819-22.